investor harm

Class action filed against Driven Brands alleging false financial statements, weak controls, and unreconciled cash from 2023, affecting fiscal years 2023-2024.

Class action lawsuit filed against $COPT alleging executives misrepresented relacorilant clinical trial strength and FDA approval prospects, harming investors.

Class action lawsuit filed against $LU alleging securities fraud, false statements, and weak internal controls from April 2023 through January 2025.

Law firm files class action against $IT for allegedly false statements on contract value, revenue projections, and consulting segment performance between February 2025-2026.

Class action filed against $SNOW alleging securities fraud over failure to disclose product efficiency impacts on consumption, revenues during June 2023-February 2024 period.

Mereo BioPharma faces class action lawsuit alleging misrepresentations regarding failed Phase 3 clinical trials, with lead plaintiff deadline April 6, 2026.

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial integrity. Investors urged to join by May 5, 2026 deadline.

Class action lawsuit filed against $PSIX alleging false statements about data center market capabilities and understated manufacturing costs between May 2025 and March 2026.

Class action lawsuit filed against $SMR alleging NuScale made false statements about partner ENTRA1's nuclear experience, concealing material risks to commercialization strategy.

Bronstein, Gewirtz & Grossman filed class action against $TCPC alleging false statements on valuations and NAV from November 2024 to January 2026.

Class action lawsuit filed against Grocery Outlet alleging securities fraud, false financial statements, and unsustainable expansion. Lead plaintiff deadline set for May 15, 2026.

Class action filed against Navan ($NAVN) alleging IPO prospectus misled investors on sales and marketing expense requirements. Claim period deadline: April 24, 2026.

Class action lawsuit filed against Beyond Meat alleging material misstatements about asset valuations and SEC filing delays during February-November 2025 period.

Class action lawsuit filed against $ENPH alleging overstatement of inventory management and tax credit mitigation capabilities, covering April-October 2025 purchases.

Class action lawsuit filed against $SLNO alleging failure to disclose safety concerns about DCCR drug candidate, including fluid retention issues in clinical trials.

Class action lawsuit filed against Eos Energy Enterprises ($EOSE) alleging executives made false statements about production capacity, battery downtime, and quality issues from November 2025 to February 2026.

Alight Inc. faces class action lawsuit alleging executives misled investors about CEO leadership, capital returns, and financial targets from November 2024 to February 2026.

Class action lawsuit filed against AMC Entertainment over alleged securities violations related to APE preferred equity units. Investors claim material misstatements about distribution rights.

Class action filed against $EOSE alleging materially false statements and non-disclosure of production delays, battery downtime, and quality control failures.

Bronstein, Gewirtz & Grossman files class action against BellRing Brands alleging false sales statements tied to inventory buildup rather than genuine demand.